These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7538815)

  • 1. A phase I trial of recombinant human interleukin-6 in patients with myelodysplastic syndromes and thrombocytopenia.
    Gordon MS; Nemunaitis J; Hoffman R; Paquette RL; Rosenfeld C; Manfreda S; Isaacs R; Nimer SD
    Blood; 1995 Jun; 85(11):3066-76. PubMed ID: 7538815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombopoietic effects and toxicity of interleukin-6 in patients with ovarian cancer before and after chemotherapy: a multicentric placebo-controlled, randomized phase Ib study.
    D'Hondt V; Humblet Y; Guillaume T; Baatout S; Chatelain C; Berlière M; Longueville J; Feyens AM; de Greve J; Van Oosterom A
    Blood; 1995 May; 85(9):2347-53. PubMed ID: 7537110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo effects of interleukin-6 on thrombopoiesis in healthy and irradiated primates.
    Zeidler C; Kanz L; Hurkuck F; Rittmann KL; Wildfang I; Kadoya T; Mikayama T; Souza L; Welte K
    Blood; 1992 Dec; 80(11):2740-5. PubMed ID: 1280477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of rhIL-11 on normal dogs and after sublethal radiation.
    Nash RA; Seidel K; Storb R; Slichter S; Schuening FG; Appelbaum FR; Becker AB; Bolles L; Deeg HJ; Graham T
    Exp Hematol; 1995 May; 23(5):389-96. PubMed ID: 7720811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of thrombocytopenia and neutropenia in a nonhuman primate model of marrow suppressive chemotherapy by combining pegylated recombinant human megakaryocyte growth and development factor and recombinant human granulocyte colony-stimulating factor.
    Harker LA; Marzec UM; Kelly AB; Cheung E; Tomer A; Nichol JL; Hanson SR; Stead RB
    Blood; 1997 Jan; 89(1):155-65. PubMed ID: 8978288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase I/II study of interleukin-3 in patients with aplastic anemia and myelodysplasia.
    Nimer SD; Paquette RL; Ireland P; Resta D; Young D; Golde DW
    Exp Hematol; 1994 Aug; 22(9):875-80. PubMed ID: 8062886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constant subcutaneous infusion of rhIL-11 in mice: efficient delivery enhances biological activity.
    Leonard JP; Neben TY; Kozitza MK; Quinto CM; Goldman SJ
    Exp Hematol; 1996 Feb; 24(2):270-6. PubMed ID: 8641352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcutaneous granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndrome: toxicity, pharmacokinetics, and hematological effects.
    Thompson JA; Lee DJ; Kidd P; Rubin E; Kaufmann J; Bonnem EM; Fefer A
    J Clin Oncol; 1989 May; 7(5):629-37. PubMed ID: 2651578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I trial of subcutaneous interleukin-6 in patients with advanced malignancies.
    Weber J; Yang JC; Topalian SL; Parkinson DR; Schwartzentruber DS; Ettinghausen SE; Gunn H; Mixon A; Kim H; Cole D
    J Clin Oncol; 1993 Mar; 11(3):499-506. PubMed ID: 7680375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential use of recombinant human interleukin-6 in clinical oncology.
    Veldhuis GJ; Willemse PH; Mulder NH; Limburg PC; De Vries EG
    Leuk Lymphoma; 1996 Feb; 20(5-6):373-9. PubMed ID: 8833392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hematologic and immunologic evaluation of recombinant human interleukin-6 in patients with advanced malignant disease: evidence for monocyte activation.
    Keever-Taylor CA; Witt PL; Truitt RL; Ramanujam S; Borden EC; Ritch PS
    J Immunother Emphasis Tumor Immunol; 1996 May; 19(3):231-43. PubMed ID: 8811498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of defective megakaryocytic development in patients with myelodysplastic syndromes.
    Hofmann WK; Kalina U; Wagner S; Seipelt G; Ries C; Hoelzer D; Ottmann OG
    Exp Hematol; 1999 Mar; 27(3):395-400. PubMed ID: 10089900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential interleukin 3 and granulocyte-macrophage-colony stimulating factor therapy in patients with bone marrow failure with long-term follow-up of responses.
    Wu HH; Talpaz M; Champlin RE; Pilat SR; Kurzrock R
    Cancer; 2003 Dec; 98(11):2410-9. PubMed ID: 14635076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase I/II study of sequential interleukin-3 and granulocyte-macrophage colony-stimulating factor in myelodysplastic syndromes.
    Nand S; Sosman J; Godwin JE; Fisher RI
    Blood; 1994 Jan; 83(2):357-60. PubMed ID: 8286736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of recombinant human interleukin-11 on rat megakaryopoiesis and thrombopoiesis in vivo: comparative study with interleukin-6.
    Yonemura Y; Kawakita M; Masuda T; Fujimoto K; Takatsuki K
    Br J Haematol; 1993 May; 84(1):16-23. PubMed ID: 8338768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of recombinant human interleukin-3 in patients with myelodysplastic syndromes.
    Ganser A; Seipelt G; Lindemann A; Ottmann OG; Falk S; Eder M; Herrmann F; Becher R; Höffken K; Büchner T
    Blood; 1990 Aug; 76(3):455-62. PubMed ID: 2378979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of thrombopoiesis in mice by fibroblast growth factor 9.
    Matsumoto-Yoshitomi S; Seko C; Kuroshima K; Naruo K; Shino A; Kondo T; Kurokawa T
    Growth Factors; 1995; 12(3):179-90. PubMed ID: 8619924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor. A phase I-II trial.
    Negrin RS; Haeuber DH; Nagler A; Olds LC; Donlon T; Souza LM; Greenberg PL
    Ann Intern Med; 1989 Jun; 110(12):976-84. PubMed ID: 2471429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase I/II trial of recombinant human interleukin-6 in patients with aplastic anaemia.
    Schrezenmeier H; Marsh JC; Stromeyer P; Müller H; Heimpel H; Gordon-Smith EC; Raghavachar A
    Br J Haematol; 1995 Jun; 90(2):283-92. PubMed ID: 7794747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple in vivo effects of interleukin-3 and interleukin-6 on murine megakaryocytopoiesis.
    Carrington PA; Hill RJ; Stenberg PE; Levin J; Corash L; Schreurs J; Baker G; Levin FC
    Blood; 1991 Jan; 77(1):34-41. PubMed ID: 1984801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.